– HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – HETRONIFLY® (serplulimab) is expected to become the first anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES-SCLC AHMEDABAD, India,…
Month: September 2024
HANSIZHUANG (serplulimab) is the world’s first anti-PD-1 mAb for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) has…
NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing capabilities and developed in-house product…
NEW YORK, Sept. 21, 2024 /PRNewswire/ — The longing for peace transcends time, geography and religion. Based on justice, human rights and universal values outlined in the UN Charter, a culture of peace brings us all together in our common agenda for humanity. We can only co-exist by…
Sur 34 Gin earns Top Distinction at the 2024 USA Spirits Ratings Competition in San Francisco. COLONIA DEL SACRAMENTO, Uruguay, Sept. 20, 2024 /PRNewswire-PRWeb/ — Uruguay has proudly brought home the award for the best gin in the world. Sur 34 Gin, the artisan gin crafted in Colonia del…
– Celebrate Charity Day and Chuseok with JungKwanJang’s Tesla Giveaway and Give a Gift of Health Initiative CERRITOS, Calif., Sept. 20, 2024 /PRNewswire/ — Cerritos, CA – Korea Ginseng Corp. US (KGCUS) aka JungKwanJang is celebrating two significant occasions this September: the…
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Methode Electronics, Inc. (NYSE: MEI), if they…
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 15, 2024 to file lead plaintiff applications in a securities class action lawsuit against Extreme Networks, Inc. (NasdaqGS: EXTR), if they…
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 30, 2024 to file lead plaintiff applications in a securities class action lawsuit against CrowdStrike Holdings, Inc. (the “Company”) (NasdaqGS:…
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 30, 2024 to file lead plaintiff applications in a securities class action lawsuit against Arbor Realty Trust, Inc. (“ABR” or the “Company”)…